List of Tables
Table 1. Global Recombinant Protein Peptide Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Recombinant Protein Peptide Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Recombinant Protein Peptide Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Recombinant Protein Peptide Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Recombinant Protein Peptide Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Recombinant Protein Peptide Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Recombinant Protein Peptide Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Recombinant Protein Peptide Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Recombinant Protein Peptide Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Protein Peptide Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Protein Peptide Drug, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Protein Peptide Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Protein Peptide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Peptide Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Protein Peptide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Recombinant Protein Peptide Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Recombinant Protein Peptide Drug Sales Market Share by Region (2020-2025)
Table 19. Global Recombinant Protein Peptide Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Recombinant Protein Peptide Drug Sales Market Share by Region (2026-2031)
Table 21. Global Recombinant Protein Peptide Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Recombinant Protein Peptide Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Recombinant Protein Peptide Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Recombinant Protein Peptide Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Recombinant Protein Peptide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Recombinant Protein Peptide Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Recombinant Protein Peptide Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Recombinant Protein Peptide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Recombinant Protein Peptide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Recombinant Protein Peptide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Recombinant Protein Peptide Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Recombinant Protein Peptide Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Recombinant Protein Peptide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Recombinant Protein Peptide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Recombinant Protein Peptide Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Recombinant Protein Peptide Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Recombinant Protein Peptide Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Recombinant Protein Peptide Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Recombinant Protein Peptide Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Protein Peptide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Recombinant Protein Peptide Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Recombinant Protein Peptide Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Recombinant Protein Peptide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant Protein Peptide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Recombinant Protein Peptide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Recombinant Protein Peptide Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Recombinant Protein Peptide Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Recombinant Protein Peptide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Recombinant Protein Peptide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Recombinant Protein Peptide Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Recombinant Protein Peptide Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Recombinant Protein Peptide Drug Sales Market Share by Type (2020-2025)
Table 53. Global Recombinant Protein Peptide Drug Sales Market Share by Type (2026-2031)
Table 54. Global Recombinant Protein Peptide Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Recombinant Protein Peptide Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Recombinant Protein Peptide Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Recombinant Protein Peptide Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Recombinant Protein Peptide Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Recombinant Protein Peptide Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Recombinant Protein Peptide Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Recombinant Protein Peptide Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Recombinant Protein Peptide Drug Sales Market Share by Application (2020-2025)
Table 63. Global Recombinant Protein Peptide Drug Sales Market Share by Application (2026-2031)
Table 64. Global Recombinant Protein Peptide Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Recombinant Protein Peptide Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Recombinant Protein Peptide Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Recombinant Protein Peptide Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Recombinant Protein Peptide Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Recombinant Protein Peptide Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Recombinant Protein Peptide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Recombinant Protein Peptide Drug Product
Table 74. Roche Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Recombinant Protein Peptide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Novartis Recombinant Protein Peptide Drug Product
Table 79. Novartis Recent Developments/Updates
Table 80. Amgen Company Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen Recombinant Protein Peptide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Amgen Recombinant Protein Peptide Drug Product
Table 84. Amgen Recent Developments/Updates
Table 85. Genentech Company Information
Table 86. Genentech Description and Business Overview
Table 87. Genentech Recombinant Protein Peptide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Genentech Recombinant Protein Peptide Drug Product
Table 89. Genentech Recent Developments/Updates
Table 90. Eli Lilly and Company Company Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Recombinant Protein Peptide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Eli Lilly and Company Recombinant Protein Peptide Drug Product
Table 94. Eli Lilly and Company Recent Developments/Updates
Table 95. Sanofi Company Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Recombinant Protein Peptide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sanofi Recombinant Protein Peptide Drug Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Biogen Company Information
Table 101. Biogen Description and Business Overview
Table 102. Biogen Recombinant Protein Peptide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Biogen Recombinant Protein Peptide Drug Product
Table 104. Biogen Recent Developments/Updates
Table 105. AstraZeneca Company Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Recombinant Protein Peptide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. AstraZeneca Recombinant Protein Peptide Drug Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Recombinant Protein Peptide Drug Distributors List
Table 113. Recombinant Protein Peptide Drug Customers List
Table 114. Recombinant Protein Peptide Drug Market Trends
Table 115. Recombinant Protein Peptide Drug Market Drivers
Table 116. Recombinant Protein Peptide Drug Market Challenges
Table 117. Recombinant Protein Peptide Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Protein Peptide Drug
Figure 2. Global Recombinant Protein Peptide Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Protein Peptide Drug Market Share by Type: 2024 & 2031
Figure 4. Recombinant Protein Hormone Product Picture
Figure 5. Peptide Drugs Product Picture
Figure 6. Recombinant Vaccine Protein Product Picture
Figure 7. Others Product Picture
Figure 8. Global Recombinant Protein Peptide Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Recombinant Protein Peptide Drug Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Global Recombinant Protein Peptide Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Recombinant Protein Peptide Drug Market Size (2020-2031) & (US$ Million)
Figure 14. Global Recombinant Protein Peptide Drug Sales (2020-2031) & (K Units)
Figure 15. Global Recombinant Protein Peptide Drug Average Price (US$/Unit) & (2020-2031)
Figure 16. Recombinant Protein Peptide Drug Report Years Considered
Figure 17. Recombinant Protein Peptide Drug Sales Share by Manufacturers in 2024
Figure 18. Global Recombinant Protein Peptide Drug Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Recombinant Protein Peptide Drug Players: Market Share by Revenue in Recombinant Protein Peptide Drug in 2024
Figure 20. Recombinant Protein Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Recombinant Protein Peptide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Recombinant Protein Peptide Drug Sales Market Share by Country (2020-2031)
Figure 23. North America Recombinant Protein Peptide Drug Revenue Market Share by Country (2020-2031)
Figure 24. United States Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Recombinant Protein Peptide Drug Sales Market Share by Country (2020-2031)
Figure 27. Europe Recombinant Protein Peptide Drug Revenue Market Share by Country (2020-2031)
Figure 28. Germany Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Recombinant Protein Peptide Drug Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Recombinant Protein Peptide Drug Revenue Market Share by Region (2020-2031)
Figure 35. China Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Recombinant Protein Peptide Drug Sales Market Share by Country (2020-2031)
Figure 43. Latin America Recombinant Protein Peptide Drug Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Recombinant Protein Peptide Drug Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Recombinant Protein Peptide Drug Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Recombinant Protein Peptide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Recombinant Protein Peptide Drug by Type (2020-2031)
Figure 53. Global Revenue Market Share of Recombinant Protein Peptide Drug by Type (2020-2031)
Figure 54. Global Recombinant Protein Peptide Drug Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Recombinant Protein Peptide Drug by Application (2020-2031)
Figure 56. Global Revenue Market Share of Recombinant Protein Peptide Drug by Application (2020-2031)
Figure 57. Global Recombinant Protein Peptide Drug Price (US$/Unit) by Application (2020-2031)
Figure 58. Recombinant Protein Peptide Drug Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
